Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,050	2,717	1,641	502	1,314	1,009
Market Cap Growth	157.40%	65.56%	227.08%	-61.83%	30.31%	9.04%
Enterprise Value	2,822	2,442	1,309	209	1,144	719
PE Ratio	-	-14.71	-9.06	-7.21	-9.81	-7.17
PS Ratio	32.88	35.09	69.42	159.06	-	-
PB Ratio	49.08	16.00	6.21	1.77	7.89	3.59
P/FCF Ratio	-18.55	-19.95	-9.45	-10.80	-10.76	-8.00
P/OCF Ratio	-18.55	-19.95	-9.46	-3.44	-10.77	-8.22
EV/Sales Ratio	30.70	31.54	55.39	66.28	-	-
EV/EBITDA Ratio	-9.41	-14.49	-7.51	-3.05	-8.58	-5.14
EV/EBIT Ratio	-9.35	-14.34	-7.44	-3.00	-8.54	-5.11
EV/FCF Ratio	-17.12	-17.93	-7.54	-4.50	-9.36	-5.70
Debt / Equity Ratio	0.02	0.01	0.01	0.01	0.02	0.01
Debt / EBITDA Ratio	0.00	-0.01	-0.01	-0.04	-0.02	-0.03
Debt / FCF Ratio	-0.01	-0.01	-0.01	-0.05	-0.03	-0.03
Quick Ratio	3.99	5.27	8.54	6.82	9.63	11.99
Current Ratio	4.35	5.58	8.90	7.10	10.10	12.39
Asset Turnover	0.29	0.23	0.07	0.01	0	0
Interest Coverage	-16.33	-12.25	-33.82	-	-	-
Return on Equity (ROE)	-179.30%	-96.00%	-74.20%	-20.80%	-63.60%	-67.70%
Return on Assets (ROA)	-87.30%	-55.00%	-54.30%	-18.60%	-58.30%	-60.30%
Return on Capital (ROIC)	-433.64%	-107.80%	-67.30%	-59.32%	-80.52%	-51.30%
Earnings Yield	-9.06%	-6.80%	-11.04%	-13.88%	-10.20%	-13.95%
FCF Yield	-4.65%	-5.01%	-10.59%	-9.26%	-9.30%	-12.51%
Buyback Yield / Dilution	-6.06%	-10.65%	-5.08%	-12.40%	-21.15%	-17.48%
Total Shareholder Return	-6.06%	-10.65%	-5.08%	-12.40%	-21.15%	-17.48%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).